Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin for blood loss in abdominal myomectomy
NCT04083625Phase 4Completed
- Sponsor
- Cairo University
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Uterine Fibroids (UF) comparing Carbetocin with Placebo (2 arms). Primary endpoint: Mean amount of intraoperative blood loss. Started Sep 2019; status: completed.
02
Drugs
carbetocin
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT04083625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04083625.